1. Hauser SL, Goodin DS. Multiple sclerosis and demyelinating diseases. In: Longo DL, Fauci AS, Kasper DL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal medicine. 18th ed. New York, NY: Mc Graw Hill Medical; 2011. p. 3395–409.
2. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:502–17.
3. Weiner HL. Multiple sclerosis is an inflammatory T-cell mediated autoimmune disease. Arch Neurol. 2004;61:1613–5.
4. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin-responsive T cells, specific for myelin basic protein and proteolipid protein, in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med. 1994;17:9973–84.
5. Viglietta V, Baecher-Allen C, Weiner HL, Haffler DA. Loss of functional suppression by CD + CD25+ regulatory T-cells in patients with multiple sclerosis. J Exp Med. 2004;199: 9973–84.